BRCA1, BRCA2, and MUTYH were the genes with the most frequent P/LPGVs in the scoping review, while MSH2 was 11th out of 28 hereditary cancer syndrome genes included for analysis [2]. This evidence concerns the gene MSH2 and Inherited cancer-predisposing syndrome.